Anti-Cancer Effects of Cyclic Peptide ALOS4 in a Human Melanoma Mouse Model

Anti-Cancer Effects of Cyclic Peptide ALOS4 in a Human Melanoma Mouse Model

We examined the effects of ALOS4, a cyclic peptide discovered previously by phage library selection against integrin α<sub>v</sub>β<sub>3</sub>, on a human melanoma (A375) xenograft model to determine its abilities as a potential anti-cancer agent. We found that ALOS4 promote...

Full description

Bibliographic Details
Main Authors: Bar Levi, Shiri Yacobovich, Michael Kirby, Maria Becker, Oryan Agranyoni, Boris Redko, Gary Gellerman, Albert Pinhasov, Igor Koman, Elimelech Nesher
Format: Article
Language:English
Published: MDPI AG 2021-09-01
Series:International Journal of Molecular Sciences
Subjects:
cancer
cyclic peptide
integrin
α<sub>v</sub>β<sub>3</sub>
ALOS4
melanoma
Online Access:https://www.mdpi.com/1422-0067/22/17/9579

Internet

https://www.mdpi.com/1422-0067/22/17/9579

Similar Items